The effect of vanadium on platelet function

Environmental Toxicology and Pharmacology

Volumn 32, Issue 3, 2011, Pages 447-456

  González Villalva, Adriana ^a   Piñón Zárate, Gabriela ^a   De la Peña Díaz, Aurora ^a,b   Flores García, Mirthala ^b   Bizarro Nevares, Patricia ^a   Rendón Huerta, Erika P ^a   Colín Barenque, Laura ^c   Fortoul, Teresa Imelda ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Inhalation; P selectin; Platelet aggregation inhibition; Vanadium; Vanadium pentoxide

Indexed keywords

CELL MARKER; PADGEM PROTEIN; VANADIUM PENTOXIDE;

AIR POLLUTANT; ANIMAL CELL; ARTICLE; BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA;

ADMINISTRATION, INHALATION; AIR POLLUTANTS; ANIMALS; BLOOD PLATELETS; CELLS, CULTURED; HUMANS; MALE; MICE; MICE, INBRED STRAINS; P-SELECTIN; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET-RICH PLASMA; VANADIUM COMPOUNDS;

MUS;

EID: 80054121510     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2011.08.010     Document Type: Article

References (81)

1. Adams B., Baker R., López A., Spencer S. Myeloproliferative disorders and the hyperviscosity syndrome. Emerg. Med. Clin. North Am. 2009, 27:459-476.
2. Afeseh Ngwa H., Kanthasamy A., Anantharam V., Song Ch, Witte T., Houk R., Kanthasamy A.G. Vanadium induces dopaminergic neurotoxicity via protein kinase C delta dependent oxidative signaling mechanisms: relevance to etiopathogenesis of Parkinson's disease. Toxicol. Appl. Pharmacol. 2009, 240(2):273-285.
3. Altamirano-Lozano M., Alvarez-Barrera L., Roldán-Reyes E. Cytogenic and teratogenic effects of Vanadium pentoxide on mice. Med. Sci. Res. 1993, 21:711-713.
4. Altamirano-Lozano M., Valverde M., Alvarez-Barrera L., Molina B., Rojas E. Genotoxic studies of vanadium pentoxide (V2O5) in male mice. II. Effects in several mouse tissues. Teratog. Carcinog. Mutagen. 1999, 19:243-255.
5. American Conference of Governmental Industrial Hygienists Vanadium pentoxide. Documentation of the Threshold Limit Values and Biological Exposure Indices 2009, ACGIH, pp. 1-9. 7th ed.
6. André P. P-selectin in haemostasis. Br. J. Haematol. 2004, 126:298-306.
7. Andrews R., Berndt M. Platelet physiology and thrombosis. Thromb. Res. 2004, 114:447-453.
8. Aragón M.A., Ayala M.E., Fortoul T.I., Bizarro P., Altamirano-Lozano M. Vanadium induced ultrastructural changes and apoptosis in male germ cells. Reprod. Toxicol. 2005, 20:127-134.
9. Assem F.L., Levy L. A review of current toxicological concerns on vanadium pentoxide and other vanadium compounds: gaps in knowledge and directions for future research. J. Toxicol. Environ. Health B 2009, 12:289-306.
10. Avila-Costa M.R., Flores E.M., Colin-Barenque L., Ordoñez J.L., Gutiérrez A.L., Niño-Cabrera H.G., Mussali-Galante P., Fortoul T.I. Nigrostriatal modifications after vanadium inhalation: an immunocytochemical and cytological approach. Neurochem. Res. 2004, 29(7):1365-1369.
11. Avila-Costa M.R., Colín-Barenque L., Zepeda-Rodríguez A., Antuna S.B., Saldivar L., Espejel-Maya G., Mussali-Galante P., Avila-Casado M.C., Reyes-Olivera A., Anaya-Martinez V., Fortoul T.I. Ependymal epithelium disruption after vanadium pentoxide inhalation: a mice experimental model. Neurosci. Lett. 2005, 381(1-2):21-25.
12. Avila-Costa M.R., Fortoul T.I., Niño-Cabrera G., Colín-Barenque L., Bizarro-Nevares P., Gutiérrez-Valdez A.L., Ordóñez-Librado J.L., Rodríguez-Lara V., Mussali-Galante P., Díaz-Bech P., Anaya-Martínez V. Hippocampal cell alterations induced by the inhalation of vanadium pentoxide (V2O5) promote memory deterioration. Neurotoxicology 2006, 27(6):1007-1012.
13. Bishayee A., Waghray A., Patel M.A., Chatterjee M. Vanadium in the detection, prevention and treatment of cancer: the in vivo evidence. Cancer Lett. 2010, 294:1-12.
14. Barceloux D.G. Vanadium. J. Toxicol. Clin. Toxicol. 1999, 37(2):265-278.
15. Byczkowski J.Z., Kulkarni A.P. Oxidative stress and pro-oxidant biological effects of vanadium. Vanadium in the Environment. Part II. Health Effects 1998, 235-264. Wiley, New York. J.O. Nriagu (Ed.).
16. Colin-Barenque L., Martinez-Hernandez N., Baiza-Gutman L.A., Avila-Costa M.R., Ordonez-Librado J.L., Bizarro-Nevares P., Rodriguez-Lara V., Piñon-Zarate G., Rojas-Lemus M., Mussali-Galante P., Fortoul T.I. Matrix metalloproteinases 2 and 9 in central nervous system and their modification after vanadium inhalation. J. Appl. Toxicol. 2008, 28(6):718-723.
17. Cooper R.G. Vanadium pentoxide. Indian J. Occup. Environ. Med. 2007, 11(3):97-102.
18. Dyszkiewicz-Korpanty A.M., Frenkel E.P., Sarode R. Approach to the assessment of platelet function: comparison between optical-based platelet-rich plasma and impedance-based whole blood platelet aggregation methods. Clin. Appl. Thromb. Hemost. 2005, 11(1):25-35.
19. Elliott M.A., Tefferi A. Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. Br. J. Haematol. 2004, 128:275-290.
20. Emeis J.J., Jirouskova M., Muchitsch E-M., Shet A.S., Smyth S.S., Johnson G.J. A guide to murine coagulation factor structure, function, assays, and genetic alterations. J. Thromb. Haemost. 2007, 5:670-679.
21. Evangelou A.M. Vanadium in cancer treatment. Crit. Rev. Oncol. Hematol. 2002, 42:249-265.
22. Faneca H., Figueiredo V.A., Tomaz I., Gonçalves G., Avecilla F., Pedroso de Lima M.C., Geraldes C.F.G., Costa Pesso J., Castro M. Vanadium compounds as therapeutic agents: some chemical and biochemical studies. J. Inorg. Biochem. 2009, 103:601-608.
23. Fortoul T.I., Quan-Torres A., Sánchez I., López I., Bizarro P., Mendoza M.L., Saldivar-Osorio L., Espejel-Maya G., Avila-Casado M.C., Avila-Costa M.R., Colin-Barenque L., Navarro-Villanueva D., Olaiz-Fernández G. Vanadium in ambient air: Concentrations in lung tissue from autopsies of Mexico city residents in the 1960s and 1990s. Arch. Environ. Health. 2002, 57(5):446-449.
24. Fortoul T.I., Rojas-Lemus M. Vanadium as an air pollutant. Vanadium its Impact on Health 2007, 1-6. Nova Science Publishers, New York. T.I. Fortoul, M.R. Avila Costa (Eds.).
25. Fortoul T.I., Piñón-Zárate G., Díaz-Bech M.E., González-Villalva A., Mussali-Galante P., Rodríguez Lara V., Colín Barenque L., Martínez Pedraza M., Montaño L.F. Spleen and bone marrow Megakaryocytes as targets for inhaled vanadium. Histol. Histopathol. 2008, 23:1321-1326.
26. Fortoul T.I., Gonzalez-Villalva A., Piñón-Zarate P., Rodriguez-Lara V., Montaño L.F. Ultrastructural Megakaryocyte modifications after vanadium inhalation in Spleen and bone marrow. J. Electron Microsc. 2009, 58:375-380.
27. George J.N. Platelets. Lancet 2000, 355:1531-1539.
28. Goc A. Biological activity of vanadium compounds. Cent. Eur. J. Biol. 2006, 1(3):314-332.
29. González-Villalva A., Fortoul Teresa I., Avila-Costa M.R., Piñón-Zárate G., Rodríguez Lara V., Martínez-Levy G., Rojas-Lemus Marcela, Bizarro Nevares P., Díaz Bech P., Mussali-Galante P., Colin-Barenque L. Thrombocytosis induced in mice after subacute and subchronic V2O5 inhalation. Toxicol. Ind. Health 2006, 22:113-116.
30. González-Villalva A., Rodríguez Lara V., Montaño L.F., Lima-Melo A., Ramírez G., Fortoul Teresa I. Blood changes generated after vanadium inhalation. Curr. Top. Toxicol. 2009, 6:31-38.
31. Halinen A.J., Komulainen H., Salonen R.O., Ruotsalainen M., Hirvonen M.R. Diesel particles induce nitric oxide production in murine alveolar macrophages and rat airways. Environ. Toxicol. Pharmacol. 1999, 7:11-18.
32. Hayashi H., Kimurat T. The effects of vanadium compounds on the activation of adenylate cyclase from rat adrenal membrane. Biochem. Biophys. Acta 1994, 869:29-36.
33. IARC (International Agency for Research on Cancer) Vanadium pentoxide. IARC Monogr. Eval. Carcinog. Risks Hum. 2006, 86:227-292.
34. Institute of Laboratory Animal Resources Commission on Life Sciences National Research Council Guide for the Care and Use of Laboratory Animals 2010, National Academies Press, Washington, D.C. 8th ed.
35. IPCS, International Programme on Chemical Safety Concise International Chemical Assessment Document. Vanadium Pentoxide and Other Inorganic Vanadium Compounds 2000, World Health Organization.
36. Jirouskova M., Shet A.S., Johnson G.J. A guide to murine platelet structure, function, assays, and genetic alterations. J. Thromb. Haemost. 2007, 5:661-669.
37. Kaushansky K. The molecular mechanisms that control thrombopoiesis. J. Clin. Invest. 2005, 115:3339-3347.
38. Kettunen J., Lanki T., Tiittanen P., Aalto P., Koskentalo T., Kulmala M., Salomaa V., Pekkanen J. Associations of fine and ultrafine particulate air pollution with stroke mortality in an area of low air pollution levels. Stroke 2007, 38:918-922.
39. Kiviluoto M., Rasanen R.A., Rissanen M. Effects on the respiratory tract of workers in a vanadium factory. Scand. J. Work Environ. Health 1979, 5:50-58.
40. Kiviluoto M., Pyy L., Pakarinen A. Clinical laboratory results of vanadium-exposed workers. Arch. Environ. Health 1980, 36:109-113.
41. Knecht E.A., Moorman W.J., Clark J.C., Hull R.D., Biagini R.E., Lynch D.W., Boyle T.J., Simon S.D. Pulmonary reactivity to vanadium pentoxide following subchronic inhalation exposure in a non-human primate animal model. J. Appl. Toxicol. 1992, 12(6):427-434.
42. Kumar S.V., Bose R., Bhattacharya S. Low doses of heavy metals disrupt normal structure and function of rat platelets. J. Environ. Pathol. Toxicol. Oncol. 2001, 20:65-75.
43. McNicol A., Robertson C., Gerrard J.M. Vanadate activate platelets by enhancing arachidonic acid release. Blood 1993, 81:2329-2338.
44. Mills N.L., Donaldson K., Hadoke P., Boon N.A., MacNee W., Cassee F.R., Sandström T., Blomberg A., Newby D.E. Adverse cardiovascular effects of air pollution. Nat. Clin. Pract. Cardiovasc. Med. 2009, 6(1):36-44.
45. Morinville A., Maysinger D., Shaver A. From vanadis to atropos: vanadium compounds as pharmacological tools in cell death signalling. Trends Pharmacol. Sci. 1998, 19:452-459.
46. Motoyashiki T., Miyake M., Yoshida A., Morita T., Ueki H. A vanadyl sulphate-bovine serum albumin complex stimulated the release o lipoprotein lipase activity from isolated rat fat pads through an increase in the cellular content of cAMP and myo-inositol 1,4,5-trisphosphate. Biol. Pharm. 1999, 22:780-786.
47. Mukherjee B., Patra B., Mahapatra S., Banerjee P., Tiwari A., Chatterjee M. Vanadium-an element of atypical biological significance. Toxicol. Lett. 2004, 150:135-143.
48. National Toxicology Program, 2002. NTP toxicology and carcinogensis studies of vanadium pentoxide (CAS No. 1314-62-1) in F344/N rats and B6C3F1 mice (inhalation). National Toxicology Program Technical Report Series, 507, pp. 1-343.
49. Nechay B.R. Mechanisms of action of vanadium. Annu. Rev. Pharmacol. Toxicol. 1984, 24:508-524.
50. Nemmar A., Hoet P., Dinsdale D., Vermylen J., Hoylaerts M., Nemery B. Diesel exhaust particles in lung acutely enhance experimental peripheral thrombosis. Circulation 2003, 107(8):1202-1208.
51. Nemmar A., Hoylaerts M., Hoet P., Nemery B. Possible mechanisms of the cardiovascular effects of inhaled particles: systemic translocation and prothrombotic effects. Toxicol. Lett. 2004, 149:243-253.
52. Nemmar A., Al-Salam A., Zia S., Dhanasekaran S., Shudadevi M., Ali B. Time-course effects of systemically administered diesel exhaust particles in rats. Toxicol. Lett. 2010, 194(3):58-65.
53. Nriagu J.O. Vanadium in the Environment 1998, A Wiley Interscience Publication, USA.
54. Nurden A.T. Qualitative disorders of platelets and megakaryocytes. J. Thromb. Haemost. 2005, 3(8):1773-1782.
55. Papaioannou A., Manos M., Karkabounas S., Liasko R., Evangelou A.M., Correia I. Solid state and solution studies of a vanadium(III)-l-cysteine compound and demonstration of its antimetastatic, antioxidant and inhibition of neutral endopepridase activities. J. Inorg. Biochem. 2004, 98:959-968.
56. Pumiglia K.M., Lau L.F., Huang Ch.K., Burroughst S., Feinstein M.B. Activation of signal transduction in platelets by the tyrosine phosphatase inhibitor pervanadate (vanadyl hidroperoxide). Biochem. J. 1992, 286:441-449.
57. Ress N.B., Chou B.J., Renne R.A., Dill J.A., Miller R.A., Roycroft J.H., Hailey J.R., Haseman J.K., Bucher J.R. Carcinogenicity of inhaled vanadium pentoxide in F344/N rats and B6C3F1 mice. Toxicol. Sci. 2003, 74:287-296.
58. Rinder H., Schuster, Rinder C.S., ChaoWang, Schweidler H., Smith B.R. Correlation of thrombosis with increased platelet turnover in thrombocytosis. Blood 1998, 91:1288-1294.
59. Rodríguez Mercado J.J., Roldán-Reyes E., Altamirano-Lozano M. Genotoxic effects of vanadium(IV) in human peripheral blood cells. Toxicol. Lett. 2003, 144:359-369.
60. Rodríguez-Mercado J.J., Altamirano-Lozano M.A. Vanadio: contaminación, metabolismo y genotoxicidad. Rev. Int. Contam. Ambient. 2006, 22(4):173-189.
61. Rojas E., Valverde M., Herrera L.A., Altamirano-Lozano M., Ostrosky-Wegman P. Genotoxicity of vanadium pentoxide evaluated by the single cell gel electrophoresis assay in human lymphocytes. Mutat. Res. 1996, 359:77-84.
62. Roldan R.E., Altamirano-Lozano M. Chromosomal aberrations, sister-chromatid exchange, cell cycle kinetics and satellite association in human lymphocytes cultures exposed to vanadium pentoxide. Mutat. Res. 1990, 245:61-65.
63. Rudez G., Janssen N., Kilinc E., Leebeek F.W., Gerlofs-Nijland M.E., Spronk M., ten Cate H., Cassee F.R., de Maat M.P.M. Effects of ambient air pollution on hemostasis and inflammation. Environ. Health Perspect. 2009, 117:995-1001.
64. Sachs U., Nieswandt B. In vivo thrombus formation in murine models. Circ. Res. 2007, 100:979-991.
65. Sadiq M., Mian A.A. Nickel and vanadium in air particulates at Dhahran (Saudi Arabia) during and after the Kuwait oil fires. Atmos. Environ. 1994, 28(13):2249-2253.
66. Schafer A.I. Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia. Blood 2006, 107(11):4214-4222.
67. Scibior A., Zaporowska H., Wolińska A., Ostrowski J. Antioxidant enzyme activity and lipid peroxidation in the blood of rats co-treated with vanadium (V+5) and chromium (Cr+3). Cell Biol. Toxicol. 2010, 26(6):509-526.
68. Schmitt A., Guichard J., Massé J.M., Debili N., Cramer E.M. Of mice and men: comparison of the ultrastructure of megakaryocytes and platelets. Exp. Hematol. 2001, 29:1295-1302.
69. Simon D., Kunicki T., Nugent D. Platelet function defects. Haemophilia 2008, 14:1240-1249.
70. Suenaga A., Ueki H. Effect of orthovanadate on platelet aggregation induced by platelet-activating factor. Biol. Pharm. Bull. 2004, 27:1859-1863.
71. Tefferi A., Gilliland D.G. The JAK2V617F tyrosine kinase mutation in myeloproliferative disorders: status report and immediate implications for disease classification and diagnosis. Mayo Clin. Proc. 2005, 80(7):947-958.
72. Toya T., Fukuda K., Takaya M., Arito H. Lung lessions induced by intratracheal instillation of vanadium pentoxide powder in rats. Ind. Health 2001, 39:8-15.
73. Tsai S.S., Goggins W.B., Chiu H.F., Yang C.Y. Evidence for an association between air pollution and daily stroke admissions in Kaohsiung, Taiwan. Stroke 2003, 34:2612-2616.
74. Tomer A. Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry. J. Biol. Regul. Homeost. Agents 2004, 18:172-177.
75. Thompson K.H., McNeill J.H. Effect of vanadyl sulfate feeding on susceptibility to peroxidative change in diabetic rats. Res. Commun. Chem. Pathol. Pharmacol. 1993, 80:187-200.
76. Villeneuve P.J., Chen L., Stieb D., Rowe B.H. Associations between outdoor air pollution and emergency department visits for stroke in Edmonton, Canada. Eur. J. Epidemiol. 2006, 21:689-700.
77. Villmow T., Kemkes-Matthes B., Matzdorff A.C. Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes. Thromb. Res. 2002, 108:139-145.
78. World Health Organization (WHO) Vanadium. Environmental Health Criteria 81 1998, WHO, Geneva.
79. Yamazaki S., Nitta H., Ono M., Green J., Fukuhara S. Intracerebral haemorrhage associated with hourly concentration of ambient particulate matter: case-crossover analysis. Occup. Environ. Med. 2007, 64(1):17-24.
80. Younes M., Strubelt O. Vanadate-induced toxicity towards isolated perfused rat livers: the role of lipid peroxidation. Toxicology 1991, 66:63-74.
81. Younes M., Kayser E., Strubelt O. Effect of antioxidants on vanadate-induced toxicity towards isolated perfused rat livers. Toxicology 1991, 70:141-149.